AbbVie, J&J to add proprietary data to AI protein model in bid to accelerate drug discovery
Posted:
Life sciences data company Apheris on Thursday announced an effort to boost the capabilities of protein AI models by uniting several pharmaceutical companies’ proprietary data. Apheris’ consortium of pharma companies is partnering with OpenFold3 — Columbia professor Mohammed AlQuraishi’s open-source dupe of AlphaFold3 — to train the model on AbbVie and Johnson & Johnson’s vast stores of structural data. The collaboration will focus on structures relevant to drug discovery, such as small molecule-protein and antibody-antigen interactions.
At-home abortions should be allowed for up to 12 weeks of pregnancy across the UK, according to academics, after a study found they were just as safe and effective as hospital care.
Read more here.
To explore possible treatments for various diseases, either animal models or human cell cultures are usually used first; however, animal models do not always mimic human diseases well, and cultures are far removed from tissue complexity. Advances in 3D printing,…
Attendees
Sponsors and Exhibitors
Agenda 2025
Contact us